Coulthard K P, Nielson H W, Schroder M, Covino A, Matthews N T, Murray R S, Van Der Walt J H
Pharmacy Department, Women's & Children's Hospital, North Adelaide, Australia.
J Paediatr Child Health. 1998 Oct;34(5):425-31. doi: 10.1046/j.1440-1754.1998.00267.x.
To determine the relative bioavailability and plasma paracetamol concentration profiles following administration of a proprietary formulation of paracetamol suppositories to postoperative children.
Study A-eight children undergoing minor surgery had blood samples collected following the rectal administration of either a 250 mg or 500 mg paracetamol suppository on one day and an equivalent oral dose on the following day. A mean dose of 13 mg/kg gave a mean Cmax (Tmax) of 7.7 mg/L (1.6 h) and 4.9 mg/L (2.0 h) following oral and rectal administration, respectively. The mean relative rectal bioavailability was 78% (95% confidence interval of 55-101%). Study B-20 children undergoing tonsillectomy and/or adenoidectomy were randomly assigned to receive a postoperative dose of 500 mg of paracetamol either as 2 x 250 mg liquid filled or 1 x 500 mg hard wax Panadol suppository. A mean dose of 25 mg/kg produced mean maximum plasma paracetamol concentrations of 13.2 mg/L and 14.5 mg/L at 2.1 and 1.9 h for the hard and liquid filled suppository, respectively. The absorption rate constants and areas under the curves suggested no difference in the rate or extent of absorption between the two formulations.
Absorption of paracetamol following rectal administration of Panadol suppositories to postoperative children is slower and reduced as compared to oral therapy. The hard wax and liquid filled products have similar absorption characteristics. The usually quoted antipyretic therapeutic range for paracetamol is 10-20 mg/L, although 5 mg/L may be effective. A single rectal dose of 25 mg/kg will obtain this lower concentration within 1 h of administration and maintain it for up to 6 h. When given in an appropriate dose for analgesia, maximum plasma paracetamol concentrations would be available in the immediate postoperative period if the rectal dose was given 2 h before the planned end of the procedure.
测定对术后儿童给予扑热息痛栓剂专利制剂后的相对生物利用度及血浆扑热息痛浓度曲线。
研究A - 8名接受小手术的儿童在某一天直肠给予250毫克或500毫克扑热息痛栓剂,次日给予等量口服剂量后采集血样。平均剂量13毫克/千克时,口服和直肠给药后的平均Cmax(Tmax)分别为7.7毫克/升(1.6小时)和4.9毫克/升(2.0小时)。平均直肠相对生物利用度为78%(95%置信区间为55 - 101%)。研究B - 20名接受扁桃体切除术和/或腺样体切除术的儿童被随机分配接受术后剂量的500毫克扑热息痛,剂型为2×250毫克液体制剂或1×500毫克硬蜡型必理通栓剂。平均剂量25毫克/千克时,硬蜡型和液体制剂的扑热息痛平均最大血浆浓度分别在2.1小时和1.9小时达到13.2毫克/升和14.5毫克/升。吸收速率常数和曲线下面积表明两种制剂在吸收速率或程度上无差异。
对术后儿童直肠给予必理通栓剂后,扑热息痛的吸收比口服治疗更慢且吸收量减少。硬蜡型和液体制剂具有相似的吸收特性。扑热息痛通常引用的解热治疗范围是10 - 20毫克/升,尽管5毫克/升可能也有效。单次直肠剂量25毫克/千克在给药后1小时内可达到该较低浓度并维持长达6小时。当给予适当剂量用于镇痛时,如果在计划手术结束前2小时给予直肠剂量,术后即刻即可达到最大血浆扑热息痛浓度。